Literature DB >> 9609903

Chronic thyroiditis: diffuse uptake of FDG at PET.

S Yasuda1, A Shohtsu, M Ide, S Takagi, W Takahashi, Y Suzuki, M Horiuchi.   

Abstract

PURPOSE: To determine the frequency and clinical importance of diffuse 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland.
MATERIALS AND METHODS: A total of 1,102 healthy subjects underwent whole-body positron emission tomography (PET). PET images were evaluated for increased diffuse FDG uptake in the thyroid gland. Serum free thyroxine and thyrotropin levels were measured in 36 subjects with increased uptake and in 36 matched control subjects without uptake. Antithyroid antibodies were also measured. Morphologic abnormalities were examined by using ultrasonography (US).
RESULTS: Diffuse FDG uptake was found in three men and 33 women; the prevalence was significantly higher in women (P < .01). Thirty-five subjects were euthyroid; one had hypothyroidism. Antithyroid antibodies were positive in 27 subjects. In most subjects, US findings facilitated the diagnosis of chronic thyroiditis. In control subjects, the positive rates for antithyroid antibodies and US abnormalities were significantly lower than those of the study group (P < .01).
CONCLUSION: Diffuse thyroidal FDG uptake may be an indicator of chronic thyroiditis. The actual prevalence of the disorder was not low in this series, and such lesions may be found incidentally at FDG PET.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9609903     DOI: 10.1148/radiology.207.3.9609903

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  29 in total

Review 1.  False-positive FDG PET uptake--the role of PET/CT.

Authors:  Sandra J Rosenbaum; Thomas Lind; Gerald Antoch; Andreas Bockisch
Journal:  Eur Radiol       Date:  2005-12-17       Impact factor: 5.315

2.  Subacute thyroiditis presenting as a focal lesion on [18F] fluorodeoxyglucose whole-body positron-emission tomography/CT.

Authors:  S H Yeo; S K Lee; I Hwang; E J Ahn
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

3.  Clinical Significance of Diffuse (18)F-FDG Uptake in Residual Thyroid Gland after Unilateral Thyroid Lobectomy.

Authors:  Hee-Sung Song; Su Jin Lee; Seok-Ho Yoon; Jandee Lee; Euy-Young Soh; Young-Sil An; Joon-Kee Yoon
Journal:  Nucl Med Mol Imaging       Date:  2011-07-26

4.  The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma.

Authors:  Sinae Lee; Taegyu Park; Soyeon Park; Kisoo Pahk; Seunghong Rhee; Jaehyuk Cho; Eugene Jeong; Sungeun Kim; Jae Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2013-12-06

5.  Cervical lymph nodes, thyroiditis and ophthalmopathy: the pleomorphic face of an immunoglobulin g4-related disease.

Authors:  Christophe Ghys; Michel Depierreux; Elçin Ozalp; Brigitte Velkeniers
Journal:  Eur Thyroid J       Date:  2014-11-29

6.  Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?

Authors:  N Muñoz Pérez; J M Villar del Moral; M A Muros Fuentes; M López de la Torre; J I Arcelus Martínez; P Becerra Massare; D Esteva Martínez; M Cañadas Garre; E Coll Del Rey; P Bueno Laraño; J A Ferrón Orihuela
Journal:  Langenbecks Arch Surg       Date:  2013-04-28       Impact factor: 3.445

7.  Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy.

Authors:  Le Min; Anand Vaidya; Carolyn Becker
Journal:  Eur J Endocrinol       Date:  2010-11-18       Impact factor: 6.664

8.  The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma.

Authors:  G Zhai; M Zhang; H Xu; C Zhu; B Li
Journal:  J Endocrinol Invest       Date:  2009-09-11       Impact factor: 4.256

Review 9.  Molecular imaging in thyroid cancer.

Authors:  T F Heston; R L Wahl
Journal:  Cancer Imaging       Date:  2010-01-20       Impact factor: 3.909

10.  Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer.

Authors:  Ja Seong Bae; Byung Joo Chae; Woo Chan Park; Jeong Soo Kim; Sung Hoon Kim; Sang Seol Jung; Byung Joo Song
Journal:  World J Surg Oncol       Date:  2009-08-10       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.